Nanofibres to Nanocomposites III Conference, in partnership with Nottingham Trent University

The Meeting Space at MediCity, the health, beauty and wellness innovation hub, will host its first national event on 27 February 2014 when the Nanotechnology Knowledge Transfer Network (NanoKTN) brings its annual one-day conference to Nottingham.

The Meeting Space at MediCity, the health, beauty and wellness innovation hub, will host its first national event on 27 February 2014 when the Nanotechnology Knowledge Transfer Network (NanoKTN) brings its annual one-day conference to Nottingham.

Nanofibres to Nanocomposites III is being organised by the NanoKTN, in partnership with Nottingham Trent University, and will enable delegates to discuss the latest UK developments in nanofibres, nanocomposites, as well as existing and emerging applications. This event will be of interest to all those who want to learn about the production and use of nanofibres in a wide range of applications, as well as meet with leading UK experts from different market sectors and academia in the nanofibres and nanocomposites areas.

MediCity is a collaboration between Boots, the UK's leading pharmacy-led health and beauty retailer and BioCity, the UK's leading life sciences incubation company and offers a venue for innovation themed conferences and events. The new innovation hub is housed in the historic D6 building on the Boots site in Beeston, Nottingham, and is the first initiative to open within the Nottingham Enterprise Zone.

The building has been refurbished to provide fully serviced office and laboratory space, designed to offer a stimulating and supportive business development environment for innovators in consumer healthcare, medical technology, diagnostics and beauty products. Support for early stage businesses based at MediCity is part-funded by the European Regional Development Fund.

The Nanofibres to Nanocomposites III programme includes a keynote by Professor Bob Stevens from Nottingham Trent University on 'The Birth of Nanofibres with Printed Plastic Electronics' followed by speakers from The Electrospinning Company, Revolution Fibres, Oxford Biomaterials, Spi3Dr LTD, University College London, and the Universities of Manchester and Surrey.

Bob Stevens, Professor of Smart Materials and Devices in Nottingham Trent University's School of Science and Technology, said: "Ultra-fine fibres, or nanofibres, which are less than one hundredth the diameter of a human hair, form the glue and communications network for living cells and can play significant roles in commercially beneficial applications.

"Nottingham Trent University is partnering with innovation hubs to make a range of novel technologies available to innovative companies, such as electrospinning and extreme ultraviolet laser cutting. We are at the heart of developing applications to help partners in this area through our ERDF-funded iSMART project, which will enable East Midlands SMEs to innovate new products using nanoscale engineering."

David Browning, Director of MediCity says: "Nanotechnology may play an increasingly important role in the development of products to manage our future health and wellness, so we are delighted to welcome experts in this field to MediCity. It also further strengthens our partnership with Nottingham Trent University and Professor Stevens' team."

For further information about the NanoKTN, and this event please visit nanoKTN or email enquiries.

  • Notes for editors

    BioCity and MediCity

    Louise Third, Director, Integra Communications: +44 (0)115 912 4350/07773 288342

    Boots UK

    Una Kent/Clare Stafford, Boots UK: +44 (0)115 959 5995

    About Boots UK

    Boots UK is the leading pharmacy-led health and beauty retailer in the UK, with close to 2,500 Boots UK stores and around 60,000 employees. Boots UK's purpose is to help customers look and feel better than they ever thought possible. Customers are at the heart of our business which is committed to providing exceptional customer and patient care, be the first choice for pharmacy and healthcare, offer innovative products 'only at Boots' such as the UK's leading skincare brand No7, all delivered with the great value our customers love. Created over 160 years ago, the Boots brand is still at the heart of the communities it serves.

    Boots UK is a member of Alliance Boots, a leading international, pharmacy-led health and beauty group delivering a range of products and services to customers. Working in close partnership with manufacturers and pharmacists, Alliance Boots is committed to improving health in the local communities it serves and helping its customers and patients to look and feel their best. Its focus is on growing its two core businesses: pharmacy-led health and beauty retailing and pharmaceutical wholesaling and distribution. Alliance Boots has a presence in more than 25* countries and employs over 108,000* people. Alliance Boots has pharmacy-led health and beauty retail businesses in nine* countries and operates more than 3,100* health and beauty retail stores, of which just over 3,000* have a pharmacy.

    *Figures are approximate as at 31 March 2013 and include associates and joint ventures.

    About the Nottingham Enterprise Zone

    In March 2011, the Alliance Boots site in Beeston, Nottingham, was awarded Enterprise Zone status by the UK Government. Enterprise Zones are designated areas with incentives to encourage the creation of new businesses, which will contribute to the growth of local and national economies.

    The Nottingham Enterprise Zone is comprised of part of the Alliance Boots site in Beeston and three other smaller sites – the Beeston Business Park, the Nottingham Science Park and the MediPark site (at Queens Medical Centre) which together make up 286 acres (116 hectares).

    The Alliance Boots site in total consists of 279 acres (113 hectares) and the Group's vision is to create a UK centre for innovation in health beauty and wellness in Nottingham. The site will offer a cost effective, high quality, centrally located site for health and wellness businesses such as business incubators, start-ups and small and medium enterprises. As well as existing buildings suitable for redevelopment, the site also includes around 100 acres (40 hectares) of brownfield land suitable for development.

    About BioCity

    BioCity specialises in the creation and development of business incubation sites for the life sciences. It provides a home for new and growing businesses and creates the right environment for tenant companies to have the strongest chance of success.

    BioCity does this by providing laboratory and office facilities on a flexible basis and access to high-end equipment, shared services, training, business support and access to investment.

    In 2012, BioCity established BioCity Scotland, nr Glasgow and in 2013 BioHub at Alderley Park nr Manchester for Astra Zeneca providing 350,000 sq ft of quality lab and office facilities.

    Over 100 companies started life in a BioCity business incubator and have raised £45m of seed capital. This growth formula has helped make BioCity an international hub for entrepreneurial activity in the life sciences.

    About MediCity

    MediCity is a collaboration between Boots, a member of Alliance Boots, and BioCity, the UK's leading life sciences incubation business. MediCity provides a stimulating and supportive business development environment for innovators in consumer healthcare, medical technology, diagnostics, and beauty products.

    MediCity is based within the Nottingham Enterprise Zone on the Alliance Boots site in Beeston. Businesses housed at MediCity will benefit from BioCity's experience of growing successful businesses in specialised incubator environments and Alliance Boots expertise in the global healthcare market.

    MediCity offers the ideal environment for both start-up and established companies to grow and achieve success. Businesses benefit from BioCity's proven track record in developing the right ecosystem for companies in the sector to thrive, and from the innovation and product development knowledge of Alliance Boots.

    Hot desks and "pods" provide the ideal working environment for individuals or small teams at the very early stages of developing a business idea. MediCity provides laboratory and office facilities on a flexible basis, access to high-end equipment, shared services, training, business support and access to investment.

    MediCity provides a venue for conferences and events of eventually up to 1,000 delegates focused on health, beauty and wellness.

    Support for the early stage businesses based at MediCity is part-funded by the European Regional Development Fund.

    About the European Regional Development Fund (ERDF) in the East Midlands

    MediCity is part financed by the Structural Funds for the East Midlands Region of the European Regional Development Fund [ERDF] Programme 2007 to 2013. The Department for Communities and Local Government is the managing authority for the European Regional Development Fund Programme, which is one of the funds established by the European Commission to help local areas stimulate their economic development by investing in projects which will support local businesses and create jobs.

Nanofibres to Nanocomposites III Conference, in partnership with Nottingham Trent University

Published on 22 January 2014
  • Category: Business; Press office; Research; School of Science and Technology

Still need help?

+44 (0)115 941 8418